Back to CITADEL ADVISORS LLC CITADEL ADVISORS LLC

IRDIRD
Showing 8 of 19 quarters

Position history for CITADEL ADVISORS LLCCITADEL ADVISORS LLC's holdings in OPUS GENETICS INC

CITADEL ADVISORS LLC holds 665,662 shares of IRD (OPUS GENETICS INC), worth $2.7M as of 2026-Q2. The position was increased (+450.6% shares). IRD represents 0.0% of CITADEL ADVISORS LLC's portfolio.

Current Value

$2.7M

Current Shares

665,662

Total Value Change

+$2.6M

Total Shares Change

+578,843

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
665,662
+450.6%
$2.7M0.0%$4.11
42
2026-Q1
Decreased
120,900
-33.1%
$550,0950.0%$4.25
0
2025-Q4
Increased
180,721
+59.3%
$363,2500.0%$1.95
34
2025-Q3
New
113,416
-
$187,1360.0%$1.79
35
2025-Q2
Exited
0
-100.0%
$00.0%$0.98
0
2025-Q1
Decreased
67,877
-61.4%
$66,6420.0%$1.01
0
2024-Q4
Increased
175,773
+102.5%
$209,1700.0%$1.12
25
2024-Q3
Increased
86,819
+515.8%
$113,7330.0%$1.29
24

Other major holders of IRD: ADAGE CAPITAL PARTNERS GP, L.L.C., BlackRock, Inc., BALYASNY ASSET MANAGEMENT L.P.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used